Genetics of Follicular Lymphoma Transformation

Laura Pasqualucci(Cancer Genetics (United States)), Hossein Khiabanian, Marco Fangazio(Cancer Genetics (United States)), Mansi Vasishtha(Cancer Genetics (United States)), Monica Messina(Cancer Genetics (United States)), Antony B. Holmes(Cancer Genetics (United States)), Peter Ouillette(University of Michigan–Ann Arbor), Владимир Трифонов, Davide Rossi, Fabrizio Tabbò(University of Turin), Maurilio Ponzoni, Amy Chadburn(Northwestern University), Vundavalli V. Murty(Columbia University), Govind Bhagat(Columbia University Irving Medical Center), Gianluca Gaïdano, Giorgio Inghirami(University of Turin), Sami N. Malek(University of Michigan–Ann Arbor), Raúl Rabadán, Riccardo Dalla‐Favera(Columbia University)
Cell Reports
January 1, 2014
Cited by 583Open Access
Full Text

Abstract

Follicular lymphoma (FL) is an indolent disease, but 30%-40% of cases undergo histologic transformation to an aggressive malignancy, typically represented by diffuse large B cell lymphoma (DLBCL). The pathogenesis of this process remains largely unknown. Using whole-exome sequencing and copy-number analysis, we show here that the dominant clone of FL and transformed FL (tFL) arise by divergent evolution from a common mutated precursor through the acquisition of distinct genetic events. Mutations in epigenetic modifiers and antiapoptotic genes are introduced early in the common precursor, whereas tFL is specifically associated with alterations deregulating cell-cycle progression and DNA damage responses (CDKN2A/B, MYC, and TP53) as well as aberrant somatic hypermutation. The genomic profile of tFL shares similarities with that of germinal center B cell-type de novo DLBCL but also displays unique combinations of altered genes with diagnostic and therapeutic implications.


Related Papers

No related papers found

Powered by citation graph analysis